,
hypercholesterolemia 82.7%,
TIA/stroke 35.7%

(Continued on next page)

108S.e18

Journal of Vascular Surgery

Hasan et al

January Supplement 2022

Supplementary Table II (online only). Continued.

Author, year
geographic area

Inclusion criteria

Exclusion criteria

Total No.
of patients (A)
combined
(B) CABG ﬁrst (C)
carotid ﬁrst

Mean
age, years

Male
sex, %

Comorbidities

Bernhard,92 1972
USA

Patients with coronary
N/A
revascularization who also
had associated signiﬁcant
extracranial
cerebrovascular
arteriosclerosis

(A) 15
(B) 1
(C) 15

58

58.06

NR

Brow et al,93 1999 UK

Patients with CAD who
underwent carotid
endarterectomy

NR

(A) 23
(B) 9
(C) 3

(A) 67
(B) NR
(C) NR

(A) 78.3
(B) 88.9
(C) 100

(A) HTN 39%, PAD 47%,
hypercholesterolemia 35%
(B) NR
(C) NR

Carrel et al,94 1992
Switzerland

Patients with coronary and NR
carotid artery disease who
underwent either
combined or staged
CEAþCABG

(A) 52
(C) 45

(A) 60.5
(C) NR

(A) 84.6
(C) NR

(A) Nicotine abuse 67.2%,
adiposity 57.8%, HTN 51.8%,
COPD 42.2%, DM 15.4%, PAD
15.4%, CRF 5.7%
(C) NR

Chiappini et al,95 2005
Italy

Patient who underwent
NR
both CABG and CEA,
either as a single-stage or
as